Article citationsMore>>

Gill, J., Hebert, C.A. and Colber, G.B. (2022) COVID-19-Associated Atypical Hemolytic Uremic Syndrome and Use of Eculizumab Therapy. Journal of Nephrology, 35, 317-321.
https://doi.org/10.1007/s40620-021-01125-8

has been cited by the following article:

• TITLE: Atypical Hemolytic Uremic Syndrome in a Post-COVID-19 Child: Its Differential Diagnosis with COVID-19, Multisystemic Inflammatory Syndrome and Outcome

  AUTHORS: Fernanda Aparecida De Oliveira Peixoto, Célia Regina Malveste Ito, André Luís Elias Moreira, Paulo Alex N. Silva, Mônica Oliveira Santos, Isabela Jubé Wastowski, Liana De Medeiros Machado Braga, Vivian Da Cunha Rabelo, Lilian Carla Carneiro, Melissa Ameloti Gomes Avelino

  KEYWORDS: MISC, COVID-19, aHUS, Children, Critical Care

  JOURNAL NAME: Open Journal of Pediatrics, Vol.12 No.4, September 5, 2022

  ABSTRACT: Pediatric Multisystemic Inflammatory Syndrome (MIS-C) is one of the most severe manifestations of SARS-CoV-2 in pediatrics [1]. This is a report of MIS-C with clinical presentation in infants with atypical Hemolytic Uremic Syndrome (aHUS).